OUTBIO UK LTD

Company number 12951542 ·

Active

This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.

OUTBIO UK LTD - Analysis Report

Company Number: 12951542

Analysis Date: 2025-07-20 11:16 UTC

Financial Health Assessment for OUTBIO UK LTD


1. Financial Health Score: D

Explanation:
The company shows minimal net assets and working capital, indicating a fragile financial condition. While it is not in immediate distress, the very thin margin between current assets and liabilities suggests vulnerability to cash flow shocks. The absence of fixed assets and very low equity base further weaken the financial robustness. Overall, the financial "vital signs" point to a company surviving on a very tight financial pulse.


2. Key Vital Signs

Metric 2024 Value (£) Interpretation
Current Assets 7,803 Includes cash and debtors; low but slightly improving
Cash 6,586 Healthy relative to total current assets but modest overall
Debtors 1,217 Limited receivables; potential delay risk if customers slow to pay
Current Liabilities 7,454 Almost equal to current assets; tight working capital
Net Current Assets (Working Capital) 349 Positive but razor-thin buffer; risk of liquidity strain
Net Assets 349 Very low equity base; minimal cushion for absorbing losses
Shareholders Funds 349 Reflects accumulated retained earnings; very minimal
Employees 0 No employees reported, possibly reliant on contractors/outsourced services

Interpretation of Vital Signs:

  • The "heartbeat" of working capital is extremely weak, with just £349 net current assets. This is akin to a patient with very low blood pressure—just enough to sustain life but highly susceptible to collapse under stress.
  • Cash reserves are the main lifeline but only amount to £6,586, which must cover all ongoing expenses and liabilities.
  • The company does not hold any fixed assets, indicating no long-term investment or collateral for borrowing.
  • The current liabilities nearly match current assets, suggesting the company is walking a financial tightrope with little margin for error.

3. Diagnosis

OUTBIO UK LTD is in a fragile financial condition. The company’s financial statements reveal a very limited asset base and minimal equity. The working capital buffer is positive but extremely narrow, which means the business could face liquidity issues if any unexpected expenses arise or if cash inflows are delayed. The absence of employees suggests a lean operational model, likely dependent on contractors, consultants, or digital services. The company is not in immediate distress but suffers from the "symptoms of financial frailty" — minimal reserves and tight cash flow that could quickly worsen if conditions deteriorate.

The company’s classification as a private limited by guarantee without share capital indicates it may be a non-profit or social enterprise structure, which often relies on external funding or grants. This would explain the low asset and equity base, but also means ongoing financial sustainability depends heavily on continued funding or income streams.


4. Recommendations

To improve its financial wellness and build resilience, OUTBIO UK LTD should consider the following actions:

  • Strengthen Cash Reserves: Build a larger cash buffer to create a safer margin for operational expenses and unexpected liabilities. This is akin to building up "body fat reserves" to survive lean periods.
  • Enhance Revenue Streams: Explore ways to increase income, diversify funding sources, or secure longer-term contracts to improve cash flow predictability.
  • Manage Creditors Proactively: Negotiate longer payment terms with suppliers or creditors to ease short-term liquidity pressures.
  • Consider Fixed Assets or Investments: If feasible, invest in assets that can serve as collateral or generate returns, improving balance sheet strength.
  • Maintain Lean Operations: Continue controlling fixed costs, possibly through outsourcing or part-time engagements, to avoid added financial strain.
  • Regular Financial Monitoring: Implement stringent cash flow forecasting and monthly financial reviews to detect early symptoms of distress.
  • Governance and Controls: Ensure that directors and significant controllers actively monitor financial health and compliance with reporting deadlines to avoid penalties and preserve trust.

Perspective: Financial Health Diagnostician · Model: gpt-4.1-mini · Generated 20 July 2025

Sign in to generate a free AI analysis of this company — no password needed, just an email link.